autoimmune Conference-Coverage

Conference Coverage

What to Expect at the IAS Virtual Meeting: Q&A With Dr Gelfand

06/19/2020

Interdisciplinary Autoimmune Summit (IAS) Senior Advisor Joel Gelfand, MD, MSCE, shared a preview of his presentations, what practice-shaping information attendees can expect at this year’s virtual meeting, and more in this interview. IAS...

Interdisciplinary Autoimmune...

06/19/2020

Autoimmune

Conference Coverage

Pharmacologic Treatment Effective for Preventing Post-Operative Recurrence of Crohn Disease

12/13/2019

Anti-tumor necrosis factor agents and/or thiopurines can prevent recurrence of Crohn disease in surgically treated patients, said Miguel Regueiro, MD, from the Cleveland Clinic, at the 2019 AIBD Meeting.

Anti-tumor necrosis factor...

12/13/2019

Autoimmune

Conference Coverage

Prior TNFi Failure Increases Adverse Events in Tofacitinib Treatment of UC

12/15/2018

Researchers sought to determine the effects of prior TNFi and/or immunosuppressant failure on the efficacy and safety of tofacitinib in patients with ulcerative colitis.

Researchers sought to determine...

12/15/2018

Autoimmune

Conference Coverage

04/27/2012

Dr Jonathan Kay of the UMass Chan Medical School explained how the advent of biosimilars in the field of immune-mediated inflammatory diseases can potentially expand access to and drive down costs of treatment without loss of safety or...

Dr Jonathan Kay of the UMass...

04/27/2012

Autoimmune

Conference Coverage

Voclosporin Shows Efficacy in Lupus Nephritis

11/23/2011

In the interim analysis of the AURORA 2 Extension Study, the addition of voclosporin to a mycophenolate mofetil and low-dose steroid treatment routine has proved effective at reducing proteinuria.

In the interim analysis of the...

11/23/2011

Autoimmune

Videos

Alexis Ogdie, MD, on The Burden of Comorbidities in Inflammatory Disorders

04/26/2011

Dr Ogdie gives a recap of her presentation at the 2022 Interdisciplinary Autoimmune Summit on common comorbidities to be aware of in patients with inflammatory disorders.

Dr Ogdie gives a recap of her...

04/26/2011

Autoimmune

Conference Coverage

Leonard Calabrese, DO, on Interdisciplinary Management of Immune-Related Adverse Events

04/23/2011

Leonard Calabrese, DO, from Cleveland Clinic, reviewed adverse events that can be caused by immunotherapy for cancer care, therapies for these immune-related effects, and the importance of consultation among oncologists, rheumatologists,...

Leonard Calabrese, DO, from...

04/23/2011

Autoimmune

Conference Coverage

Popular Articles

Stay In the Know

Specialties

Events

Year Round Education

HMP Global Products